Obesity does not protect against subarachnoid haemorrhage

Written By :  Hina Zahid
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-12-03 03:30 GMT   |   Update On 2021-12-03 03:30 GMT

Subarachnoid haemorrhage (SAH) is a life-threatening condition that kills, in contrast to other cerebrovascular disturbances, primarily healthy people of working age. Whereas smoking and high blood pressure are the most well-known risk factors associated with the condition, the role of many other lifestyle risk factors as causes of SAH has been unclear.For a long time, obesity has been...

Login or Register to read the full article

Subarachnoid haemorrhage (SAH) is a life-threatening condition that kills, in contrast to other cerebrovascular disturbances, primarily healthy people of working age. Whereas smoking and high blood pressure are the most well-known risk factors associated with the condition, the role of many other lifestyle risk factors as causes of SAH has been unclear.

For a long time, obesity has been linked with a heightened risk of developing a number of diseases of the cardiovascular system, but findings pertaining to subarachnoid haemorrhage have been the opposite: the condition appears to occur at a lower frequency in overweight (body mass index 25–30) and obese individuals (body mass index >30) compared to underweight and normal-weight people. While the same observation has been repeatedly made in population-based follow-up studies, no explanation has been identified.

A study carried out by Finnish and Norwegian researchers published in the distinguished Stroke journal investigated whether obesity actually protects against subarachnoid haemorrhage. Unlike in prior studies, this was the first time that researchers comprehensively considered factors that may confound the findings, including people's smoking habits and the prevalence of hypertension.

The results were very clear: obesity does not protect against subarachnoid haemorrhage. According to Ilari Rautalin, the first author of the study, the findings provide a simple explanation of the previous observations.

"Smoking is much more common among underweight and normal-weight people than overweight and obese people. Neglecting to take smoking habits into account produces a false observation of subarachnoid haemorrhage occurring less often in obese people, since smoking is less common among them than others," explains Rautalin, MD, from the University of Helsinki.

A study based on a dataset of over 200,000 people

A research dataset containing follow-up data for more than 200,000 individuals collected over almost 50 years was utilised in the study. Miikka Korja, docent of neurosurgery and the principal investigator of the study, emphasises the significance of extensive and high-quality research datasets.

"This collaborative Nordic study serves, once again, as an excellent illustration of why studies on the risk factors associated with cerebral haemorrhage should be based on large and high-quality research datasets. Risk factors related to lifestyle are rarely independent of one another, which makes it challenging to investigate their interconnections. It's easy to draw incorrect conclusions on the independent effects of individual risk factors," notes Korja, head of section at the Department of Neurosurgery of the Helsinki University Hospital.

In conclusion, Rautalin and Korja emphasise that while the effect of obesity itself appears to be minor in connection with subarachnoid haemorrhage, many other adverse health effects caused by obesity should be taken into consideration. Therefore, the researchers recommend that the goal should continue to be to achieve and maintain normal weight, refrain from smoking as well as effectively prevent and treat hypertension.

https://www.ahajournals.org/doi/10.1161/STROKEAHA.121.034782

Tags:    
Article Source : Stroke

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News